How Many Evolent Health Inc (NYSE:EVH)’s Analysts Are Bullish?

July 26, 2017 - By Henry Gaston

 How Many Evolent Health Inc (NYSE:EVH)'s Analysts Are Bullish?

Evolent Health Inc (NYSE:EVH) Ratings Coverage

Among 11 analysts covering Evolent Health (NYSE:EVH), 11 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health had 16 analyst reports since August 7, 2015 according to SRatingsIntel. JP Morgan reinitiated the shares of EVH in report on Friday, October 28 with “Overweight” rating. The company was maintained on Wednesday, June 21 by Oppenheimer. On Friday, January 13 the stock rating was upgraded by Wells Fargo to “Outperform”. The rating was maintained by JP Morgan with “Overweight” on Monday, March 14. The stock has “Outperform” rating by FBR Capital on Tuesday, March 29. FBR Capital maintained the stock with “Outperform” rating in Friday, August 5 report. The company was initiated on Tuesday, July 26 by Jefferies. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, January 6. Jefferies maintained the stock with “Buy” rating in Friday, July 7 report. The firm earned “Buy” rating on Wednesday, June 14 by Robert W. Baird. Below is a list of Evolent Health Inc (NYSE:EVH) latest ratings and price target changes.

07/07/2017 Broker: Jefferies Rating: Buy New Target: $28.0000 Maintain
27/06/2017 Broker: Cowen & Co Rating: Buy New Target: $35.0000
21/06/2017 Broker: Oppenheimer Rating: Buy New Target: $28.0000 Maintain
19/06/2017 Broker: Leerink Swann Rating: Buy New Target: $32.0000
14/06/2017 Broker: Robert W. Baird Rating: Buy New Target: $35.0000 Maintain
02/06/2017 Broker: Robert W. Baird Rating: Outperform New Target: $30 Initiates Coverage On

It closed at $26.2 lastly. It is down 80.60% since July 26, 2016 and is uptrending. It has outperformed by 63.90% the S&P500.

Evolent Health, Inc. is engaged in healthcare delivery and payment. The company has market cap of $1.78 billion. The Firm supports health systems and physician organizations in their migration toward value care and population health management. It currently has negative earnings. The Firm provides an end-to-end, technology-enabled services platform for providers.

More notable recent Evolent Health Inc (NYSE:EVH) news were published by: Reuters.com which released: “Exclusive: Evolent Health explores merger with Advisory Board – sources” on March 24, 2017, also Benzinga.com with their article: “What The Street Gets Wrong About Evolent Health, Cowen’s ‘Best Small-Mid Cap Idea'” published on June 27, 2017, Bizjournals.com published: “Report: Evolent Health weighs merger with Advisory Board” on March 27, 2017. More interesting news about Evolent Health Inc (NYSE:EVH) were released by: Prnewswire.com and their article: “Evolent Health Announces First Quarter 2017 Results” published on May 09, 2017 as well as Prnewswire.com‘s news article titled: “Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of …” with publication date: May 16, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.